Platelet Rich Plasma has been used for years to treat chronic wounds. In a landmark decision, the Centers for Medicare and Medicaid Services (CMS) announced coverage for PRP that is being used in clinical trials for wound healing. This is a crucial first step for a broad range of biologic therapies. If government payers are willing to support these types of treatments when they are backed up with appropriate data, more innovative treatments will arise. This is good news for patients and the providers who are developing novel options for difficult problems.
Full Story Link
Allan Mishra, MD